Apigenin Market - By Type (0.95, 0.98), By Application (Pharma and Healthcare, Food Additives, Cosmetic and Skin Care), By Region & Global Forecast, 2023 – 2032

Apigenin Market Size

Apigenin Market size reached USD 300 thousand in 2022 and is estimated to grow at over 3.8% CAGR between 2023 and 2032. The market for natural and plant-based ingredients is witnessing significant growth as consumers increasingly seek healthier and more sustainable options. The rising demand for natural and plant-based products in industries such as pharmaceuticals, cosmetics, and food and beverages will stimulate business development.
 

As consumers become more health-conscious and seek natural remedies and supplements, the awareness and demand for apigenin as a dietary supplement or ingredient in functional foods and beverages are increasing. The growing body of research supporting the health benefits of apigenin is driving market growth.

One pitfall for the apigenin market could be the limited availability and extraction challenges. Although apigenin is naturally present in several plant sources, extracting it in large quantities can be challenging and costly. The limited availability and extraction difficulties may result in potential supply constraints, leading to fluctuations in pricing and availability of apigenin. Moreover, the reliance on specific plant sources for apigenin extraction raises concerns about sustainability and potential environmental impacts, necessitating careful management and alternative sourcing strategies to mitigate these challenges.
 

COVID-19 Impact

The pandemic has heightened global awareness of health and wellness, leading to an increased demand for natural and plant-based ingredients with potential health benefits. As a result, the apigenin market has showcased a surge in demand, particularly in the pharmaceutical and dietary supplement sectors. The focus on immunity-boosting and preventive healthcare has propelled the interest in natural compounds like apigenin, contributing to market growth. The pandemic has caused disruptions in global supply chains, including those for raw materials and ingredients. This disruption has affected the availability of apigenin from certain plant sources, leading to challenges in sourcing and production. Supply chain disruptions and logistical constraints have resulted in potential delays and increased costs, impacting the apigenin demand.
 

Apigenin Market Trends

Apigenin has been studied extensively for its potential therapeutic properties, including antioxidant, anti-inflammatory, anti-cancer, and neuroprotective effects. This has led to increased interest in utilizing apigenin in the development of pharmaceutical drugs and nutraceutical products. As research on apigenin continues to advance, the identification of new therapeutic applications and formulations is likely to influence the market growth. There is a significant emphasis on research and development activities within the apigenin business. As the understanding of apigenin's properties and potential applications expands, there is a continuous effort to explore its efficacy, safety, and interactions. Research initiatives are aimed at discovering novel uses, optimizing extraction methods, and enhancing the bioavailability of apigenin.
 

Apigenin Market Analysis

Based on type, the apigenin market is segmented as 0.95, 0.98 & Others. The 0.95 type segment accounted for USD 182.1 thousand in 2022 and is slated to exhibit more than 4% CAGR up to 2032. A 0.95 purity level indicates a high-quality product with a standardized concentration of apigenin. This level of purity ensures consistency and reliability in terms of the active compound content, which is crucial for research, formulation, and product development. In scientific research and pharmaceutical applications, it is often desirable to have a well-defined and concentrated form of apigenin. Researchers require precise control over the dosage and composition of the compound to study its effects and potential applications. A higher purity level allows for more accurate experimentation and analysis.
 

Based on application, the Apigenin market is segmented as pharma & healthcare, food additives, cosmetic & skin care, and others. In 2022 pharma & healthcare held majority market value of USD 127.2 thousand and is predicted to surpass 191.2 thousand by 2032. Apigenin has been extensively studied for its potential therapeutic properties, including its antioxidant, anti-inflammatory, anticancer, neuroprotective, and antimicrobial effects. These properties make apigenin a valuable compound for pharmaceutical applications.
 

The pharmaceutical industry utilizes apigenin in the development of drugs, supplements, and therapies for various health conditions, such as cancer, inflammation-related disorders, and neurodegenerative diseases. Apigenin, a naturally occurring flavonoid compound, is utilized in the food industry as a food additive for various purposes including as a flavoring agent, antioxidant, and colorant. Food Additives Market size valued at USD 100 billion in 2022 and is projected to register 7% CAGR from 2023 to 2032.
 

North America Apigenin market revenue crossed USD 144.1 thousand In 2022 and is expected to reach USD 209.7 thousand by 2032. North America has witnessed a rising demand for natural and plant-based ingredients in various industries, including pharmaceuticals, nutraceuticals, and cosmetics. Consumers are increasingly conscious of their health and seek products derived from natural sources. Apigenin, being a natural compound found in plants, aligns well with this consumer preference, driving its demand in the market.
 

North America has a well-established regulatory framework for the pharmaceutical and nutraceutical industries. The region's regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, provide guidelines and approvals for the use of natural compounds like apigenin in various applications. This supportive regulatory environment business statistics by ensuring safety, quality, and compliance with industry standards.
 

Apigenin Market Share

Notable players in the apigenin market are :

• Indofine Chemical Company Inc.
• Cayman Chemical Company
• TCI Chemicals
• Sigma-Aldrich (Merck KGaA)
• ChemFaces
• Extrasynthese.

These companies are actively engaged in the production, distribution, and research of apigenin, positioning themselves as leading contributors to the market.

Apigenin Industry News:

• In May 2023, Bravado Labs, a manufacturer of health and wellness supplements launched a new apigenin product. This product is specifically developed to enhance the overall well-being of individuals who prioritize their health. It is an ideal choice for those seeking a natural remedy to promote healthy aging, alleviate stress, improve sleep quality, and provide support for prostate health.
   

This apigenin market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Tons and revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Type

• 0.95
• 0.98
• Others

By Application

• Pharma and Healthcare
• Food Additives
• Cosmetic and Skin Care
• Others

By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE